CHARACTERIZING THE HYPERMUTATED SUBTYPE OF ADVANCED PROSTATE CANCER AS A PREDICTIVE BIOMARKER FOR PRECISION MEDICINE
$561,229FY2014Department of the ArmyDOD
University Of Washington, Seattle WA
Investigators
View source on USAspending →CHARACTERIZING THE HYPERMUTATED SUBTYPE OF ADVANCED PROSTATE CANCER AS A PREDICTIVE BIOMARKER FOR PRECISION MEDICINE · GrantIndex